Quinpirole dihydrochloride
Quinpirole dihydrochloride structure
|
Common Name | Quinpirole dihydrochloride | ||
|---|---|---|---|---|
| CAS Number | 73625-62-4 | Molecular Weight | 255.78700 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H22ClN3 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of Quinpirole dihydrochloriderel-Quinpirole (rel-LY 141865) dihydrochloride, an ergot compound, is a selective dopamine (DA) D2 receptor agonist. rel-Quinpirole dihydrochloride can be used for research on neurological diseases[1]. |
| Name | (-)-quinpirole hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | rel-Quinpirole (rel-LY 141865) dihydrochloride, an ergot compound, is a selective dopamine (DA) D2 receptor agonist. rel-Quinpirole dihydrochloride can be used for research on neurological diseases[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C13H22ClN3 |
|---|---|
| Molecular Weight | 255.78700 |
| Exact Mass | 255.15000 |
| PSA | 31.92000 |
| LogP | 2.73880 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae.
J. Neurosci. 31 , 5512-25, (2011) An imbalance in dopamine-mediated neurotransmission is a hallmark physiological feature of neuropsychiatric disorders, such as schizophrenia. Recent evidence demonstrates that dopamine D(2) receptors,... |
|
|
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.
Hum. Mol. Genet. 24(7) , 1929-44, (2015) The essential micronutrient manganese is enriched in brain, especially in the basal ganglia. We sought to identify neuronal signaling pathways responsive to neurologically relevant manganese levels, a... |
|
|
Biphasic effect of D-2 agonist quinpirole on locomotion and movements.
Eur. J. Pharmacol. 161 , 151-157, (1989) The effects of the D-2 agonist quinpirole on forward progression, and on vertical and lateral movements, were measured for 2 h in rats injected with either saline, 0.03, 0.125, 0.5 or 8 mg/kg of the d... |
| (+/-)-quinpirole dihydrochloride |